ACXP / Acurx Pharmaceuticals, Inc. - Aliran Opsi Saham

Acurx Pharmaceuticals, Inc.

ACXP / Acurx Pharmaceuticals, Inc. - Aliran Opsi Saham

Pasar opsi dianggap sebagai uang pintar, dan dengan memantau perdagangan opsi yang dilakukan, kita dapat mengidentifikasi sinyal bullish atau bearish. Produk aliran opsi Fintel mendapatkan data perdagangan hampir secara real-time dan menyaringnya untuk menampilkan perdagangan blok besar yang kemungkinan besar dilakukan oleh lembaga. Dengan mengamati PEMBUKAAN posisi CALL atau PUT besar, kita bisa mendapatkan indikator sentimen hampir secara real-time.

Lihat juga: Papan Peringkat Saham kami dan Papan Peringkat ETF kami.

The following symbols provide the background for understanding the "side" column in the table. This column shows where in the bid/offer spread the trade was priced. This positioning can be a clue to how aggressive the trader was.
O--|---
Traded below bid (sold)
-O-|---
Traded on the bid (sold)
--O|---
Traded between mid and bid (sold)
---O---
Traded at mid market
---|O--
Traded between mid and ask/offer (bought)
---|-O-
Traded on the ask/offer (bought)
---|--O
Traded above ask/offer (bought)
Premium Sigmas
Premium Sigmas is the number of standard deviations of the premium from the mean. Any standard deviation above 2 (two) indicates a premium size that is a significant deviation from the norm (ie, extraordinary large), and we highlight it in bold.
Date Time Symbol Trade
Side
Side Contract Expiry DTX Strike
Price
Spot
Price
Strike
/ Spot %
Cond Event Trade Open Int IVOL Premium
Paid ($)
Premium
Sigmas
2025-07-11 09:37:35 ACXP SELL -O-|--- PUT 2026-01-16 189 1 0.49505 102.00 MULTI-SWEEP 734 2.21 22,575 6.58
2025-06-24 11:04:52 ACXP 2025-07-18 24 0.5913
2025-06-24 11:04:52 ACXP 2025-07-18 24 0.5913
2025-06-17 09:33:56 ACXP 2025-06-20 3 1.00494
2025-06-17 09:33:57 ACXP 2025-06-20 3 1.005
2024-07-15 11:03:32 ACXP 2024-08-16 32 2.4
2024-02-20 14:34:49 ACXP 2024-03-15 24 2.93 SSR
Other Listings
DE:3ZO0
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista